Top news of the week: 27.10.2020.

#BioTech #statturns5 #innovation #health #precisiononcology

Healthcare

On Oct 22, 2020
@jonathanrockoff shared
How two Turkish immigrants in Germany teamed up with $PFE to develop what may be the first Covid-19 vaccine to hit the market, by @bopanc and @JaredSHopkins https://t.co/aUAiOjXNrW. "Project Lightspeed," $BNTX called its program.
Open

How Pfizer Partner BioNTech Became a Leader in Coronavirus Vaccine Race

How Pfizer Partner BioNTech Became a Leader in Coronavirus Vaccine Race

German biotech BioNTech SE worked on cancer treatments, and was developing an influenza vaccine with Pfizer Inc., when its founder, Ugur Sahin, led the company’s pivot to the coronavirus in ...

On Oct 22, 2020
@megtirrell shared
@TheDomino The latest - from @wsj’s great piece on Oxford vaccine odyssey (it does seem like a British thing): https://t.co/9CtpTtUxmO https://t.co/N0LDCrXYhk
Open

Oxford Developed Covid Vaccine, Then Scholars Clashed Over Money

Oxford Developed Covid Vaccine, Then Scholars Clashed Over Money

An early deal with Merck was scotched for fear poor countries would be left out; now the university could make over $100 million with AstraZeneca if the technology succeeds.

On Oct 25, 2020
@BiotechSweden shared
Kala FDA Decision, Merck & Pfizer Earnings, Vaccine Updates And IPOs #BioTech via https://t.co/2sI0UxJbpn https://t.co/amV8RfUApb
Open

The Week Ahead In Biotech: Kala FDA Decision, Merck & Pfizer Earnings, Vaccine Updates And IPOs

The Week Ahead In Biotech: Kala FDA Decision, Merck & Pfizer Earnings, Vaccine Updates And IPOs

Biotech stocks posted weekly declines in the week ended Oct. 23, pressured by the broader market decline amid mixed earnings reports and the impasse on fiscal stimulus. After...

On Oct 26, 2020
@matthewherper shared
Happy birthday @statnews! It's ready for kindergarten! Seriously: a look back at science and medicine’s biggest headlines and controversies. #statturns5 https://t.co/n0hybpgN28
Open

As STAT turns 5, a look back at science and medicine’s biggest headlines and controversies

As STAT turns 5, a look back at science and medicine’s biggest headlines and controversies

As STAT celebrates its five-year anniversary, our reporters took a look back at areas we’ve covered closely and cast an eye to the future.

On Oct 26, 2020
@BiotechSweden shared
Inhaled antibody drug for COVID-19 clears coronavirus in animals https://t.co/0J3G6CdLtD
Open

Inhaled antibody drug for COVID-19 clears coronavirus in animals

Inhaled antibody drug for COVID-19 clears coronavirus in animals

An inhaled neutralizing antibody cleared the novel coronavirus from infected hamsters at a far lower dose compared with other experimental monoclonal antibodies. The drug is now being ...

On Oct 23, 2020
@BiotechSweden shared
Biden And Trump Drug Pricing Policies Would Decimate Biotech, Drive Innovation To China #BioTech #health #innovation via https://t.co/2sI0UxJbpn https://t.co/QOZDSYEWqm
Open

Biden And Trump Drug Pricing Policies Would Decimate Biotech, Drive Innovation To China

Biden And Trump Drug Pricing Policies Would Decimate Biotech, Drive Innovation To China

With anxiety already high over current drug supply lines, these policies would leave the country dependent on China for future medicines.

On Oct 25, 2020
@BiotechSweden shared
Bharat Biotech plans to unveil Covid vaccine by June 2021 #BioTech via https://t.co/2sI0UxJbpn https://t.co/pLNhagu570
Open

Bharat Biotech plans to unveil Covid vaccine by June 2021

Bharat Biotech plans to unveil Covid vaccine by June 2021

Bharat Biotech plans to launch the indigenously developed Covid-19 vaccine by June 2021. The pharma company was given nod to continue with phase III clinical trials on October 22. Covaxin ...

On Oct 26, 2020
@CDRLifeSciences shared
RT @Abingworthbio: Portfolio News: Scorpion Therapeutics, a next-generation #precisiononcology company, has closed a $108M Series A financing, led by @atlasventure, Omega Funds & @vidaventures, & including @Abingworthbio & Partners HealthCare Innovation. https://t.co/rX7liHedoT
Open

Scorpion Therapeutics Launches with $108 Million to Advance Precision Oncology 2.0

Scorpion Therapeutics Launches with $108 Million to Advance Precision Oncology 2.0

Scorpion Therapeutics, Inc. today announced the closing of a $108 million Series A financing.